Sinopep has sufficient experience in filing and submitting documents to authorities both home and abroad. The Chemical, Manufacturing and Control (CMC) documents provided by Sinopep, such as DMF (drug master file),enable the competent authorities (e.g. FDA, EMA) to review the information of API, in order to evaluate issuing Marketing Authorization to drug applicants. In addition to submitting registration documents in the United States and Europe, Sinopep also has rich experience in registration declaration in China.
EptifibatideEpitifibatide is an antiplatelet drug of the glycoprotein IIb / IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from the protein found in the venom of the
BivalirudinBivalirudin is a synthetic hirudin analogue, a specific and reversible direct thrombin inhibitor.
Octreotide AcetateOctreotide is a long-acting synthetic octapeptide analogue of natural somatostatin. Octreotide inhibits the secretion of gastric-intestinal-pancreatic polypeptide hormones and
Lanreotide AcetateLanreotide is a synthetic analogue of somatostatin, its properties are similar to Octreotide
LiraglutideLiraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist